Antenatal betamethasone administration alters stress physiology in healthy neonates. 2009

Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
From the Department of Obstetrics and Gynecology, University of Zuürich, Zuürich, Switzerland; and the Department of Pediatrics, University of Erlangen, Erlangen, Germany.

OBJECTIVE To analyze hypothalamic-pituitary-adrenal axis balance in healthy newborns after antenatal betamethasone treatment for lung maturation where delivery could be prolonged until or near term. METHODS In a prospective observational study, salivary cortisol and cortisone levels were measured at the fourth day of life during resting conditions and in response to a pain-induced stress event in 23 neonates with antenatal exposure to a single course of betamethasone (2x12 mg) and compared with 40 controls. The mean interval between betamethasone treatment and delivery was 60+/-23 days. RESULTS On day 4 of life, neonates in the control group exhibited a significant increase in cortisol and cortisone from baseline levels after the stress induction (1.175-2.4 ng/mL for cortisol and 11.35-18.15 ng/mL for cortisone [both P<.05]), whereas, in betamethasone-exposed neonates, cortisol and cortisone stress response was not significantly different from baseline levels (1.39-1.6 ng/mL for cortisone [P=.76] and 14.8-17.1 ng/mL for cortisol [P=.69]). No influence of gestational age at betamethasone administration (P=.76) or gestational age at delivery (P=.71) on stress response patterns was observed in a multiple stepwise regression. CONCLUSIONS A single course of antenatal betamethasone treatment induces a suppression of stress reactivity in healthy newborns.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D008297 Male Males
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D003348 Cortisone A naturally occurring glucocorticoid that has been used in replacement therapy for ADRENAL INSUFFICIENCY and as an anti-inflammatory agent. Cortisone itself is inactive; it is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726) 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate,Adreson,Cortisone Acetate,Cortone Acetate
D005260 Female Females

Related Publications

Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
August 2009, American journal of perinatology,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
February 2018, Journal of perinatology : official journal of the California Perinatal Association,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
October 2010, Pediatric research,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
September 2004, Psychoneuroendocrinology,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
April 1999, Lancet (London, England),
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
March 2011, Obstetrics and gynecology,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
January 1983, European journal of clinical pharmacology,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
April 2001, Pediatric research,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
January 2012, Clinical therapeutics,
Leonhard Schäffer, and Franziska Luzi, and Tilo Burkhardt, and Manfred Rauh, and Ernst Beinder
December 2013, Journal of the renin-angiotensin-aldosterone system : JRAAS,
Copied contents to your clipboard!